Skip to content

Evaluation of Reflex Tear Production

Evaluation of Reflex Tear Production

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06565624
Enrollment
40
Registered
2024-08-22
Start date
2024-10-17
Completion date
2024-11-07
Last updated
2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Disease

Keywords

Reflex Tear Production

Brief summary

The purpose of this study is to evaluate reflex tear production following cotton swab nasal stimulation in subjects with dry eye disease (DED).

Detailed description

The primary analysis will assess the change from baseline (pre- versus immediately post-cotton swab nasal stimulation) in tear meniscus height (TMH) using optical coherence tomography (OCT). This study will consist of one visit on a single day.

Interventions

PROCEDURECotton Swab Nasal Stimulation

Nostril probing for the purpose of producing reflex tearing

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Within the last 12 months, have a previous history of dry eye disease, either clinician diagnosed or patient reported. * Within the last 6 months, have used, or desired to use artificial tears for dry eye symptoms. * Corrected Visual Acuity (Snellen) 20/200 or better in both eyes. * Good general and ocular health, as determined by the investigator using medical history, ophthalmic examination and history. * Able, as assessed by the investigator, and willing to follow study instructions. * Other protocol-specified inclusion criteria may apply. Key

Exclusion criteria

* Current evidence of any clinically significant ophthalmic disease other than dry eye (for example, glaucoma or macular degeneration). * Use of artificial tears within 2 hours of the Study Visit. * History of ocular surgery within 1 year of the Study Visit. * Use of contact lenses in either eye within 7 days of the Study Visit. * Use of lid hygiene (all forms of lid care) or heat masks within 7 days of the Study Visit. * Use of any topical ocular anti-inflammatory medications, any topical ocular corticosteroid, or any non-steroidal-anti-inflammatory agents within 30 days of the Study Visit. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in TMH immediately following stimulationDay 1 pre-stimulation (Baseline); Day 1 immediately post-stimulationTMH (the distance between the line of reflection along the top of the tear prism to the edges of the eyelids) will be measured in millimeters using OCT, a non-invasive imaging test that uses light waves to take cross-section pictures of the eye. TMH will be assessed prior to nasal stimulation and upon completion of nasal stimulation. Only one eye will be assessed by OCT.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026